News
Marco Schilling

Matthias Tschöp receives Hector Science Award

29 Jan 2025 | Press Release | Award

This year, Matthias H. Tschöp, CEO of Helmholtz Munich and SyNergy member, and Stefanie Dehnen, a chemist at the Karlsruhe Institute of Technology (KIT), have been awarded the prestigious Hector…

Ali Ertürk / Helmholtz Munich

SCP-Nano: A new technology to visualize banocarriers in cells and tissues

14 Jan 2025 | Press Release

How can we ensure that life-saving drugs or genetic therapies reach their intended target cells without causing harmful side effects? Researchers at Helmholtz Munich, Ludwig-Maximilians-Universität…

 Matthias Brendel

Alzheimer’s: new strategy for amyloid diagnostics

22 Nov 2024 | Press Release

A research group at LMU University Hospital has investigated how Alzheimer’s disease can be diagnosed more reliably in the future.

Research Spotlight

Alzheimer’s disease: Amyloid drives the spread of tau by evoking neuronal hyperconnectivity

13 Feb 2025 | Research Spotlight

The Amyloid Cascade model of Alzheimer’s disease suggests that plaques of amyloid-β (Aβ) are the primary cause of the disease and trigger other pathological changes, such as the spread of abnormal…

Podcast

57 Clusters of Excellence, 1 podcast. This episode of “Exzellent erklärt - Spitzenforschung für alle” focuses on our research with Thomas Misgeld and Anna-Sophia Wahl. Topics include research into common neurological diseases such as Alzheimer's, multiple sclerosis and stroke, the self-healing powers of the brain and the Cluster's interdisciplinary approach. Current advances in repair mechanisms, the importance of neuronal plasticity and the use of modern technologies such as AI for research are discussed.

SyNergy is:

8
Partner
55
Mitglieder
27
Tandem-Projekte
2973
Publikationen

The Cluster of Excellence SyNergy (Munich Cluster for Systems Neurology) investigates how complex neurological diseases such as Alzheimer's and Parkinson's Disease, stroke, or multiple sclerosis develop. Even though these diseases differ significantly in their clinical manifestations, overlapping mechanisms are involved in their development. Using systems neurology as a new interdisciplinary approach, researchers can better map the processes involved in neurovascular, neurodegenerative, and neuroimmunological diseases and develop approaches for novel therapies. The cluster has been funded by the German Research Foundation (DFG) since 2012.